Articles:

Understanding error grid analysis

DJ Cox, LA Gonder-Frederick, BP Kovatchev, DM Julian, and WL Clarke
Diabetes Care 1997 20: 911-912.  

The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study

DW Dunstan, TA Mori, IB Puddey, LJ Beilin, V Burke, AR Morton, and KG Stanton
Diabetes Care 1997 20: 913-921. [Abstract]  

Glucocorticoid-induced ketoacidosis in gestational diabetes: sequela of the acute treatment of preterm labor. A case report

A Bedalov and A Balasubramanyam
Diabetes Care 1997 20: 922-924. [Abstract]  

Contraindications to metformin therapy in patients with NIDDM

TV Sulkin, D Bosman, and AJ Krentz
Diabetes Care 1997 20: 925-928. [Abstract]  

Contribution of central neuropathy to postural instability in IDDM patients with peripheral neuropathy

L Uccioli, PG Giacomini, P Pasqualetti, S Di Girolamo, P Ferrigno, G Monticone, E Bruno, P Boccasena, A Magrini, L Parisi, G Menzinger, and PM Rossini
Diabetes Care 1997 20: 929-934. [Abstract]  

A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study

AR Folsom, M Szklo, J Stevens, F Liao, R Smith, and JH Eckfeldt
Diabetes Care 1997 20: 935-942. [Abstract]  

Gestational diabetes is a herald of NIDDM in Navajo women. High rate of abnormal glucose tolerance after GDM

JR Steinhart, JR Sugarman, and FA Connell
Diabetes Care 1997 20: 943-947. [Abstract]  

Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy

JG Kotsanos, L Vignati, W Huster, C Andrejasich, MB Boggs, AM Jacobson, D Marrero, SD Mathias, D Patrick, S Zalani, and J Anderson
Diabetes Care 1997 20: 948-958. [Abstract]  

A trial of cognitive analytic therapy in poorly controlled type I patients

JA Fosbury, CM Bosley, A Ryle, PH Sonksen, and SL Judd
Diabetes Care 1997 20: 959-964. [Abstract]  

Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins

MR Christie, U Roll, MA Payton, EC Hatfield, and AG Ziegler
Diabetes Care 1997 20: 965-970. [Abstract]  

Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement. Findings from a large urban health maintenance organization

K Wisdom, JP Fryzek, SL Havstad, RM Anderson, MC Dreiling, and BC Tilley
Diabetes Care 1997 20: 971-977. [Abstract]  

Relationship between weight change in young adulthood and the risk of NIDDM. The Sotetsu Study

Y Sakurai, K Teruya, N Shimada, K Wakabayashi, T Umeda, S Honjo, I Todoroki, H Tanaka, T Muto, M Sakurai, and K Nakamura
Diabetes Care 1997 20: 978-982. [Abstract]  

IDDM incidence in a multiracial population. The Hawaii IDDM Registry, 1980-1990

SL Patrick, JK Kadohiro, SH Waxman, JD Curb, TJ Orchard, JS Dorman, LH Kuller, and RE LaPorte
Diabetes Care 1997 20: 983-987. [Abstract]  

Age and sex effects on HbA1c. A study in a healthy Chinese population

YC Yang, FH Lu, JS Wu, and CJ Chang
Diabetes Care 1997 20: 988-991. [Abstract]  

Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM

MC Riddle, PA McDaniel, and LA Tive
Diabetes Care 1997 20: 992-994. [Abstract]  

Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients

N Sato, K Kashima, Y Uehara, K Ohtani, H Shimizu, and M Mori
Diabetes Care 1997 20: 995-998. [Abstract]  

Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study

YM Smulders, M Rakic, CD Stehouwer, RN Weijers, EH Slaats, and J Silberbusch
Diabetes Care 1997 20: 999-1005. [Abstract]  

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM

TJ Berg, K Dahl-Jorgensen, PA Torjesen, and KF Hanssen
Diabetes Care 1997 20: 1006-1008. [Abstract]  

Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy

D Muhr, U Mollenhauer, AG Ziegler, M Haslbeck, E Standl, and O Schnell
Diabetes Care 1997 20: 1009-1012. [Abstract]  

Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia

P Perros, IJ Deary, RJ Sellar, JJ Best, and BM Frier
Diabetes Care 1997 20: 1013-1018. [Abstract]  

Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension

M Nannipieri, G Penno, L Rizzo, L Pucci, S Bandinelli, P Mattei, S Taddei, A Salvetti, and R Navalesi
Diabetes Care 1997 20: 1019-1026. [Abstract]  

The limitations of clinical trials for prevention of IDDM

JL Mahon and J Dupre
Diabetes Care 1997 20: 1027-1033.  

Reservations on the use of error grid analysis for the validation of blood glucose assays

DA Gough and EL Botvinick
Diabetes Care 1997 20: 1034-1036.  

The 32nd annual meeting of the European Association for the Study of Diabetes. Neuropathy, health care, and glycation

ZT Bloomgarden
Diabetes Care 1997 20: 1037-1039.  

Declaration of the Americas on Diabetes

Diabetes Care 1997 20: 1040-1041.  

The American Diabetes Association's Clinical Practice Recommendations and the developing world

J Akhter
Diabetes Care 1997 20: 1044-1045.  

Neonatal diabetes

JP Shield, WM Howell, and IK Temple
Diabetes Care 1997 20: 1045-1046.  

Is hyperinsulinemia the cause of acanthosis nigricans in the type B syndrome of insulin resistance?

JW Eriksson
Diabetes Care 1997 20: 1045.  

Nutritional intake of Belgian diabetic children

H Dorchy and K Bourguet
Diabetes Care 1997 20: 1046-1047.  

Mixing insulin lispro and ultralente insulin

EJ Bastyr, JH Holcombe, JH Anderson, and JN Clore
Diabetes Care 1997 20: 1047-1048.  

Letters:

Influence of long-term glycemic control on the development of cardiac autonomic neuropathy in pediatric patients with type I diabetes

M Holder, RW Holl, J Bartz, W Hecker, E Heinze, HE Leichter, and W Teller
Diabetes Care 1997 20: 1042-1043.  

Prevalence of a polymorphism of the phosphatidylinositol 3-kinase p85 alpha regulatory subunit (codon 326 Met-->Ile) in Japanese NIDDM patients

M Kawanishi, Y Tamori, J Masugi, H Mori, C Ito, T Hansen, CB Andersen, O Pedersen, and M Kasuga
Diabetes Care 1997 20: 1043.  

Antibodies to GAD in chronic hepatitis C patients

S Hieronimus, A Fredenrich, A Tran, S Benzaken, and P Fenichel
Diabetes Care 1997 20: 1044.  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.